Addiction - STAT

Paul Ryan, Kevin McCarthy, Greg Walden

Politics

Major opioids legislation is taking shape. Can it make a dent in a national epidemic?

Politics

NIH spells out $500 million plan to improve addiction treatment and pain management

advertisement

Truth Opioid Epidemic

Health

Crashing cars into walls, breaking hands with hammers: How the White House is warning against opioids

advertisement

Opioid Lobbying

Politics

As opioids legislation gains steam, efforts to address crisis collide with moneyed interests

opioid overdose memorial

First Opinion

Reviving an old book to tell a new story about OxyContin, Purdue, and the Sackler family

By Barry Meier

Angels in America

First Opinion

‘Angels in America’ again: It’s time to humanize addiction

By Sandeep Kapoor

FDA Opioid Tech

Politics

Facebook, Instagram among tech firms called to Washington by FDA to address illicit opioid sales

advertisement

Opioid Lawyers

First Opinion

Opioid recovery teams benefit from the addition of lawyers

By Gregory M. Singleton and Jay Chaudhary

advertisement

Runnin'

Don't Miss

“Runnin’”: a new documentary from STAT

Opioid Withdrawal

Health

In a first, FDA approves drug meant to mitigate symptoms of opioid withdrawal

Opioids Field Testing - Fentanyl

Health

Fentanyl and other synthetic opioids contributed to more overdose deaths in 2016 than prescription painkillers

Dr. Kurt Rasmussen

Politics

Former Lilly researcher will lead government agency studying addiction treatments

Food addiction

In the Lab

They were commercial flops. But can weight loss drugs be used to treat addiction?

By Meghana Keshavan

Fighter cockpit

First Opinion

Using Air Force ‘boldface’ to ease the opioid crisis

By Jim Huizenga

Methadone

Health

Nursing homes routinely refuse people on addiction treatment — which some experts say is illegal

By Allison Bond

Recreational marijuana

First Opinion

Easing access to marijuana is not a way to solve the opioid epidemic

By Nicholas Chadi and Sharon Levy

Future naloxone

Biotech

The next naloxone? Companies, academics search for better overdose-reversal drugs

By Max Blau

Jessica Nickel/Addiction Policy Forum

Politics

With the drug industry as its partner, an addiction policy group invites tough questions

Surgeon General Jerome Adams

Health

In rare advisory, surgeon general urges public to carry overdose-reversal medication

By Andrew Joseph

Oxycodone script

Health

Why Houston and other cities want nothing to do with the massive national opioid lawsuit

By Andrew Joseph

Prison Drug Treatment

Politics

Trump opioid plan writes in favoritism to single company’s addiction medication

Trump - opioid crisis - NH

First Opinion

Why Trump’s opioid plan falls short

By Michael Botticelli

Hoarding Opioids

Health

Kentucky could become the first state to tax opioid prescriptions

By Andrew Joseph

Dr. Yasmin Hurd - Mt. Sinai

In the Lab

This scientist is testing a marijuana ingredient as a way to prevent relapse. It’s a daunting task

By Megan Thielking

US Capitol dome

Politics

New opioid bill would impose sweeping limits on some prescriptions, boost funding

Dr. Jennifer Clarke

Health

A prison system offered all inmates addiction treatment. Overdose deaths dropped sharply

By Andrew Joseph

Sarah Sherbert

Health

How best to treat opioids’ youngest sufferers? No one knows

By Associated Press

Dr. Ali Rezai

In the Lab

Risky tactic, desperate need: Trial to test brain implants for opioid addiction

By Max Blau

Kratom capsules

Politics

FDA calls kratom an ‘opioid’ and warns against using the supplement

By Eric Boodman